{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:15:26Z","timestamp":1790252126679,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007955","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000}}],"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1126235"],"award-info":[{"award-number":["OPP1126235"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K021222\/1"],"award-info":[{"award-number":["MR\/K021222\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N028376\/1, MC_PC_16052 and MC_PC_14111"],"award-info":[{"award-number":["MR\/N028376\/1, MC_PC_16052 and MC_PC_14111"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007955","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T13:40:54Z","timestamp":1577367654000},"page":"e0007955","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7614-8787","authenticated-orcid":true,"given":"Celina","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1781-0053","authenticated-orcid":true,"given":"Malick M.","family":"Gibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7160-6275","authenticated-orcid":true,"given":"Shaun H.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1107-0365","authenticated-orcid":true,"given":"Xinxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Ardrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaith","family":"Aljayyoussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3598-7784","authenticated-orcid":true,"given":"Brian","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo A.","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-1405","authenticated-orcid":true,"given":"Nicholas A.","family":"Feasey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-719X","authenticated-orcid":true,"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,12,26]]},"reference":[{"key":"pntd.0007955.ref001","first-page":"3099","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","author":"JD Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"pntd.0007955.ref002","unstructured":"Gay FP. Typhoid fever considered as a problem of scientific medicine [Internet]. 1918. Available: http:\/\/www.archive.org\/details\/cu31924000230502"},{"key":"pntd.0007955.ref003","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"CM Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"pntd.0007955.ref004","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events","volume":"47","author":"VK Wong","year":"2015","journal-title":"Nat Genet"},{"key":"pntd.0007955.ref005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"E Tacconelli","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"pntd.0007955.ref006","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)00530-7","article-title":"Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: An open-label, two-centre, randomised controlled trial","volume":"16","author":"A Arjyal","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"pntd.0007955.ref007","article-title":"Salmonella enterica serovar Typhi Producing CTX-M-15 Extended Spectrum \u03b2-Lactamase in the Democratic Republic of the Congo","author":"MF Phoba","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pntd.0007955.ref008","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1473-3099(19)30176-8","article-title":"Ceftriaxone-resistant Salmonella Typhi in a traveller returning from a mass gathering in Iraq","volume":"19","author":"G Godbole","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"pntd.0007955.ref009","doi-asserted-by":"crossref","first-page":"e00105","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins","volume":"9","author":"EJ Klemm","year":"2018","journal-title":"MBio"},{"key":"pntd.0007955.ref010","article-title":"Outbreak investigation of ceftriaxone-resistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad, Pakistan: a matched case-control study","author":"FN Qamar","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"pntd.0007955.ref011","first-page":"1","article-title":"Multidrug resistant enteric fever in South Asia: Unmet medical needs and opportunities","volume":"364","author":"CM Parry","year":"2019","journal-title":"BMJ"},{"key":"pntd.0007955.ref012","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0924-8579(02)00187-5","article-title":"Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes","volume":"20","author":"IH Hall","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"pntd.0007955.ref013","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.00447-06","article-title":"Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever","volume":"51","author":"CM Parry","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0007955.ref014","first-page":"1736","article-title":"A comparative study of efficacy and safety of azithromycin and ofloxacin in uncomplicated typhoid fever: A randomised, open labelled study","volume":"6","author":"M Chandey","year":"2012","journal-title":"J Clin Diagnostic Res"},{"key":"pntd.0007955.ref015","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.43.6.1441","article-title":"Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance","volume":"43","author":"NI Girgis","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0007955.ref016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002188","article-title":"A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam","volume":"3","author":"C Dolecek","year":"2008","journal-title":"PLoS One"},{"key":"pntd.0007955.ref017","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","article-title":"A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever","volume":"44","author":"NT Chinh","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0007955.ref018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/44.2.243","article-title":"Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India","volume":"44","author":"T Butler","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"pntd.0007955.ref019","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/382359","article-title":"Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents","volume":"38","author":"RW Frenck","year":"2004","journal-title":"Clin Infect Dis"},{"key":"pntd.0007955.ref020","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/317450","article-title":"Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children","volume":"31","author":"RW Frenck","year":"2000","journal-title":"Clin Infect Dis"},{"key":"pntd.0007955.ref021","first-page":"594531","article-title":"Emergence and molecular basis of azithromycin resistance in typhoidal Salmonella in Dhaka, Bangladesh","author":"Y Hooda","year":"2019","journal-title":"bioRxiv"},{"key":"pntd.0007955.ref022","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(94)92604-2","article-title":"Azithromycin and typhoid","volume":"343","author":"M Wallace","year":"1994","journal-title":"Lancet"},{"key":"pntd.0007955.ref023","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM197001082820201","article-title":"Evaluation fo Chloramphenicol Acid Succinate Therapy of Induced Typhoid Fever and Rocky Mountain Spotted Fever","volume":"282","author":"H DuPont","year":"1970","journal-title":"N Engl J Med"},{"key":"pntd.0007955.ref024","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"C Jin","year":"2017","journal-title":"Lancet"},{"key":"pntd.0007955.ref025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197009242831306","article-title":"Typhoid fever: pathogenesis and immunologic control","volume":"283","author":"RB Hornick","year":"1970","journal-title":"N Engl J Med"},{"key":"pntd.0007955.ref026","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/ciu078","article-title":"An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution","volume":"58","author":"CS Waddington","year":"2014","journal-title":"Clin Infect Dis"},{"key":"pntd.0007955.ref027","doi-asserted-by":"crossref","first-page":"e0004926","DOI":"10.1371\/journal.pntd.0004926","article-title":"Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a","volume":"10","author":"TC Darton","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007955.ref028","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix042","article-title":"Evaluation of the clinical and microbiological response to salmonella paratyphi a infection in the first paratyphoid human challenge model","volume":"64","author":"HC Dobinson","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pntd.0007955.ref029","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1038\/ncomms12827","article-title":"An extended genotyping framework for Salmonella enterica serovar Typhi, the cause of human typhoid","volume":"7","author":"VK Wong","year":"2016","journal-title":"Nat Commun"},{"key":"pntd.0007955.ref030","article-title":"The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies","author":"MM Gibani","year":"2018","journal-title":"Clin Infect Dis"},{"key":"pntd.0007955.ref031","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1038\/psp.2013.80","article-title":"Population pharmacokinetics of azithromycin in whole blood, peripheral blood mononuclear cells, and polymorphonuclear cells in healthy adults","volume":"3","author":"MR Sampson","year":"2014","journal-title":"CPT pharmacometrics Syst Pharmacol"},{"key":"pntd.0007955.ref032","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","article-title":"Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R","volume":"34","author":"MN Neely","year":"2012","journal-title":"Ther Drug Monit"},{"key":"pntd.0007955.ref033","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/dkf079","article-title":"Pharmacokinetic\/pharmacodynamic modelling of ciprofloxacin 250 mg\/12 h versus 500 mg\/24 h for urinary infections","volume":"50","author":"MD Sanchez Navarro","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"pntd.0007955.ref034","first-page":"36","article-title":"Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets","volume":"13","author":"Q Zhao","year":"2014","journal-title":"Malar J. BioMed Central"},{"key":"pntd.0007955.ref035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CMR.00002-15","article-title":"Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections","volume":"28","author":"JA Crump","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"pntd.0007955.ref036","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1128\/JCM.36.6.1683-1687.1998","article-title":"Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance","volume":"36","author":"J Wain","year":"1998","journal-title":"J Clin Microbiol"},{"key":"pntd.0007955.ref037","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"G Foulds","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"pntd.0007955.ref038","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/BF01975832","article-title":"The Pharmacokinetics of Azithromycin and Their Clinical Significance","volume":"10","author":"H Lode","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"pntd.0007955.ref039","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/AAC.43.1.163","article-title":"Pharmacokinetics in Serum and Leukocyte Exposures of Oral Azithromycin, 1500 Milligrams, Given over a 3- or 5-Day Period in Healthy Subjects","volume":"43","author":"GUYW Amsden","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0007955.ref040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.b1865","article-title":"A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: Meta-analysis","volume":"338","author":"D Thaver","year":"2009","journal-title":"BMJ"},{"key":"pntd.0007955.ref041","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.trstmh.2004.08.007","article-title":"A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos","volume":"99","author":"S Phongmany","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0007955.ref042","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1371\/journal.pntd.0001163","article-title":"The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy","volume":"5","author":"CM Parry","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007955.ref043","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s101560070016","article-title":"Comparative uptake of grepafloxacin and ciprofloxacin by a human monocytic cell line, THP-1","volume":"6","author":"T Hara","year":"2000","journal-title":"J Infect Chemother"},{"key":"pntd.0007955.ref044","doi-asserted-by":"crossref","first-page":"e0007868","DOI":"10.1371\/journal.pntd.0007868","article-title":"Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance. Azman AS, editor","volume":"13","author":"Y Hooda","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007955.ref045","unstructured":"BioSamples: EMBL-EBI [Internet]. [cited 15 Jun 2019]. Available: https:\/\/www.ebi.ac.uk\/biosamples\/samples\/SAMEA5577691"},{"key":"pntd.0007955.ref046","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1715474","article-title":"Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa","volume":"378","author":"JD Keenan","year":"2018","journal-title":"N Engl J Med"},{"key":"pntd.0007955.ref047","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1817213","article-title":"Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa","volume":"380","author":"JD Keenan","year":"2019","journal-title":"N Engl J Med"},{"key":"pntd.0007955.ref048","first-page":"477","article-title":"Typhoid vaccines: WHO position paper\u2013March 2018","volume":"93","author":"WHO","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"pntd.0007955.ref049","first-page":"1","volume-title":"Global action plan on antimicrobial resistance","author":"World Health Organization","year":"2015"},{"key":"pntd.0007955.ref050","unstructured":"European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics [Internet]. 2019. Available: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/quinolone-fluoroquinolone-article-31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf"},{"key":"pntd.0007955.ref051","first-page":"250142","article-title":"Laboratory and Molecular Surveillance of Paediatric Typhoidal Salmonella in Nepal: Antimicrobial Resistance and Implications for Vaccine Policy","author":"C Britto","year":"2018","journal-title":"PLoS Negl Trop Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007955","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T13:33:09Z","timestamp":1578490389000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007955"}},"subtitle":[],"editor":[{"given":"Andrew S.","family":"Azman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,26]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007955","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,26]]}}}